Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.


Spring 2024

American Gastroenterological Association Logo

American Gastroenterological Association

The American Gastroenterological Association awarded $300,000 to support a Dana-Farber study into pancreatic ductal adenocarcinoma (PDAC), an aggressive disease that currently has limited and short-lasting treatment options. This funding will enable Jeffrey Patterson-Fortin, MD, PhD, to gain insights into how PDAC responds to immune-based therapies that could provide longer term benefit for patients.
A photo of a couple in front of a body water

Julie Wallace Bennett

With a $250,000 gift, Julie Wallace Bennett established the Peter Warren Fund for Pancreatic Research, in honor of her partner, Peter. Brian Wolpin, MD, MPH, the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber will lead this research.
The Cancer Couch Foundation Logo

The Cancer Couch Foundation

The Cancer Couch Foundation has granted $225,000 to support the work of Daniel Abravanel, MD, PhD. The funds will drive Abravanel’s research on how drug resistance arises in metastatic breast cancer and foster the development of innovative strategies for improving treatments for patients with this challenging form of the disease.
Green lab equipment

Charles A. King Trust

The Charles A. King Trust Postdoctoral Research Fellowship Program, administered by Health Resources in Action, awarded grants totaling $412,400 to support studies into genetic and epigenetic changes that occur in cancer progression, with the goal of identifying new therapeutic targets.
A photo of a couple outside in the country side

Carol and Peter Clark

Carol and Peter Clark made a $300,000 estate gift through their donor-advised fund and charitable remainder trust to support the Jimmy Fund. The Clark Family has long supported the Jimmy Fund through the Jimmy Fund WMass Classic golf tournament and other fundraising and volunteer activities.
Load More Briefs

Winter 2023

Steaming beaker and pipette in the lab

Jonathan and Hope Ashner

A generous $100,000 gift from Jonathan and Hope Ashner was made to support the research of Elizabeth Buchbinder, MD. The gift will help to fuel Buchbinder’s groundbreaking investigations into melanoma and maximize progress against the disease.
A doctor and patient smile for a photo

Doron Broman

Doron Broman, a Miami-based real estate developer and stage IV pancreatic cancer patient, has given $150,000 to support research in pancreatic cancer under the direction of Kimmie Ng, MD, MPH. Broman came to Dana-Farber in 2015 with only months to live, but under the treatment of Ng, has defied the odds and is celebrating seven years since his diagnosis.
Colorful lab equipment

Jeffrey and Jennifer Goldstein

Jeffrey and Jennifer Goldstein made a generous gift in support of Pasi Jänne, MD, PhD, director of the Carole M. and Philip L. Lowe Center for Thoracic Oncology at Dana-Farber. The gift will support Jänne and his team’s continued research into targeted therapies in lung cancer, novel EGFR inhibitors, and mechanisms of drug resistance, ultimately helping more patients and their families.
Blue lab equipment

Matthew Miller

Matthew Miller gave $100,000 to advance groundbreaking investigations in melanoma led by Rizwan Haq, MD, PhD. Miller’s support will help Haq uncover the genomic intricacies of drug resistance and explore new ways to enhance personalized medicine for patients.
National Foundation for Cancer Research logo

National Foundation for Cancer Research

Dana-Farber recently received a $110,000 grant from the National Foundation for Cancer Research to study new, non-invasive approaches to identify specific subtypes of kidney cancer and particular genetic alterations in prostate cancer, with the aim of creating earlier detection and treatment interventions for patients with these diseases.
Load More Briefs

Fall 2023

American Association for Cancer Research

American Association for Cancer Research

The American Association for Cancer Research (AACR) recently awarded $480,000 to four Dana-Farber physician-scientists who are investigating new methods of prevention, diagnosis, and treatment for various types of cancers. As the first cancer research organization dedicated to preventing and curing cancer, AACR is a long-standing partner in Dana-Farber’s mission to defy cancer.
Glenn Foundation and American Federation for Aging Research

American Federation for Aging Research

The Glenn Foundation for Medical Research and the American Federation for Aging Research awarded a $300,000 grant to support basic science research by Dana-Farber’s Edward Chouchani, PhD, as he seeks to systematically define the functional targets of reactive oxygen species that contribute to longevity and age.
B.A.A. 5K runners participating on Dana-Farber's team pose for a photo on the Boston Common

B.A.A. 5K®

The B.A.A 5K® took place April 15, welcoming the largest team to date of Dana-Farber runners who collectively raised $184,271. Runners had the option to race in person on the 3.1-mile course that began and ended in the Boston Common, or run in their own neighborhoods as virtual teammates. The top fundraiser honor went to David Mullen.
Dana-Farber donors pose for a photo

Richard and Sandra Bornstein

Sandra Bornstein and her late husband, Richard, made a generous commitment of $400,000 to support early career physician-scientists on the leukemia and stem cell transplant teams at Dana-Farber. Faculty excellence is a top priority of The Dana-Farber Campaign, and this funding will help fuel the growth of promising investigators as they work to ensure greater numbers of patients live longer, healthier lives.
Liquid pouring from a beaker into a petri dish

Clifford Family

The Clifford Family established the Woolley-Clifford Foundation Fund with a $100,000 gift, supporting the research of David Kozono, MD, PhD, as he works to investigate blood and tissue-based biomarkers in lung cancer patients that can help predict lung inflammation and anti-tumor response following radiation therapy.
Load More Briefs

Summer 2023

Andrea McGrath and Corey Cutler, MD, MPH, FRCPC

20 Years of Survivorship

In 2022, Andrea McGrath celebrated 20 years since her successful stem cell transplant at Dana-Farber. She hosted a survivorship event, raising over $16,000 to benefit the work of her doctor and now friend, Corey Cutler, MD, MPH, FRCPC, whose advances in stem cell transplantation are continuing to improve outcomes for blood disorder patients like her.
3000 Miles To A Cure

3000 Miles to a Cure

3000 Miles to a Cure awarded $100,000 to support the ALLELE-GBM research program at Dana-Farber, under the direction of Keith Ligon, MD, PhD. Ligon’s team is working to put genomic data into the hands of patients, providers, and researchers to advance treatments and clinical trials in glioblastoma (GBM).
Colorful lab equipment

Barbara and Arnold Barron

Barbara and Arnold Barron gave $100,000 to support lung cancer research under the direction of Michael Rabin, MD. The couple has supported the work of Rabin and Dana-Farber for many years, this gift marking their latest commitment to spur advancements in durable treatments for lung cancer patients at Dana-Farber and around the globe.
Various tubes and other lab equipment

Charles A. King Trust

The Charles A. King Trust Postdoctoral Research Fellowship Program, administered by Health Resources in Action, awarded grants totaling $246,776 to two Dana-Farber fellows working in small cell lung cancer and leukemia, as part of the trust’s mission to promote the investigation of human disease, to alleviate suffering through improved treatment.
Children's Cancer Research Fund

Children’s Cancer Research Fund

Children’s Cancer Research Fund awarded their Emerging Scientist Award to Dana-Farber pediatric oncologist Emily Heikamp, MD, PhD, MSc. The grant of $100,000 will support Heikamp’s work in uncovering therapeutic vulnerabilities in the NU98-r gene, which could lead to safer and more effective treatments for children with relapsed acute myeloid leukemia.
Load More Briefs

Spring 2023

Stacked petri dishes

Margaret and Michael Bayer

Margaret and Michael Bayer gave $100,000 to establish The Bayer Family Research Fund. The fund aims to accelerate discoveries into safer, more effective and durable treatments for patients facing Waldenström’s macroglobulinemia, a rare form of blood cancer.
People on the field at Fenway Park

Boston Red Sox Jimmy Fund Award

The 2022 Boston Red Sox Jimmy Fund Award—the Jimmy Fund’s highest honor—was presented to John Berardi (second from right), program director of Jimmy Fund Little League presented by Franklin Sports, which rallies thousands of youth baseball and softball players each summer to fundraise for the Jimmy Fund in their communities and has raised over $6 million for Dana-Farber since 1986.
Breast Cancer Alliance Logo

Breast Cancer Alliance

Breast Cancer Alliance awarded $125,000 to Dana-Farber to support research into the features of the tumor microenvironment that result in metastatic triple-negative breast cancer (TNBC). This work will improve researchers’ knowledge of the behavior of TNBC and may help identify patients who are more likely to benefit from treatments such as immunotherapy.
Clear beakers

Fred and Michele Brettschneider

Fred and Michele Brettschneider made a commitment of $250,000 to support a clinical trial network for Waldenström’s macroglobulinemia and advance all clinical research for this rare form of blood cancer within the Bing Center for Waldenström’s Macroglobulinemia.
Lab equipment

Burlingame Foundation

The Burlingame Foundation gave $300,000 to provide support for patient navigation through the Cancer Care Equity Program (CCEP). Patient navigation involves supporting and assisting patients through the complexities of treatment—a key component of the CCEP’s effort to address disparities in cancer care.
Load More Briefs